AU4903999A - Salts of paroxetine - Google Patents
Salts of paroxetine Download PDFInfo
- Publication number
- AU4903999A AU4903999A AU49039/99A AU4903999A AU4903999A AU 4903999 A AU4903999 A AU 4903999A AU 49039/99 A AU49039/99 A AU 49039/99A AU 4903999 A AU4903999 A AU 4903999A AU 4903999 A AU4903999 A AU 4903999A
- Authority
- AU
- Australia
- Prior art keywords
- acid
- carboxylic
- benzoic
- phenyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9814316 | 1998-07-02 | ||
| GBGB9814316.7A GB9814316D0 (en) | 1998-07-02 | 1998-07-02 | Novel compounds |
| PCT/EP1999/004543 WO2000001692A1 (en) | 1998-07-02 | 1999-06-30 | Salts of paroxetine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4903999A true AU4903999A (en) | 2000-01-24 |
Family
ID=10834803
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU49039/99A Abandoned AU4903999A (en) | 1998-07-02 | 1999-06-30 | Salts of paroxetine |
| AU2002100370A Expired AU2002100370A4 (en) | 1998-07-02 | 2001-07-11 | Novel compound |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002100370A Expired AU2002100370A4 (en) | 1998-07-02 | 2001-07-11 | Novel compound |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1091958A1 (no) |
| JP (1) | JP2002519421A (no) |
| KR (1) | KR20010053337A (no) |
| CN (1) | CN1314906A (no) |
| AP (1) | AP2000002017A0 (no) |
| AU (2) | AU4903999A (no) |
| BG (1) | BG105204A (no) |
| BR (1) | BR9911679A (no) |
| CA (1) | CA2336470A1 (no) |
| CZ (1) | CZ20004923A3 (no) |
| EA (1) | EA200100098A1 (no) |
| GB (1) | GB9814316D0 (no) |
| HU (1) | HUP0103712A3 (no) |
| ID (1) | ID27766A (no) |
| IL (1) | IL140385A0 (no) |
| NO (1) | NO20006547L (no) |
| PL (1) | PL345365A1 (no) |
| SK (1) | SK20242000A3 (no) |
| TR (1) | TR200100055T2 (no) |
| WO (1) | WO2000001692A1 (no) |
| ZA (2) | ZA992899B (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1534305E (pt) | 2003-05-07 | 2007-02-28 | Osteologix As | Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis |
| SI2266584T1 (sl) | 2003-05-07 | 2012-12-31 | Osteologix A/S, Symbion | Sestavek s stroncijem in vitaminom D za profilakso in/ali zdravljenje patologij hrustanca in/ali kosti |
| KR101165614B1 (ko) | 2004-02-26 | 2012-07-18 | 오스테올로지스 에이에스 | 괴사성 골 질환의 예방 또는 치료에 사용하기 위한스트론튬 함유 화합물 |
| EP1744770A2 (en) | 2004-05-06 | 2007-01-24 | Osteologix A/S | High yield and rapid syntheses methods for producing metallo-organic salts |
| KR100672184B1 (ko) | 2004-09-21 | 2007-01-19 | 주식회사종근당 | 파록세틴의 콜린산 또는 콜린산 유도체 염 |
| ES2745411T3 (es) | 2006-07-27 | 2020-03-02 | Wang Nai Fang | Compuestos y composiciones de arilsulfanilo para administración de agentes activos |
| CN109212055B (zh) * | 2018-08-19 | 2021-05-07 | 丁立平 | 一种测定饮用水中四种痕量单卤代苯乙酸的气相色谱-质谱联用法 |
| CN109342633B (zh) * | 2018-11-27 | 2020-10-02 | 北京市化工职业病防治院 | 尿液中苯、甲苯和二甲苯代谢物的检测方法 |
| CN111337460B (zh) * | 2018-12-18 | 2021-09-17 | 中国科学院大连化学物理研究所 | 一种高稳定性Halo-tag探针及其合成和生物应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
| EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
| CA2206592A1 (en) * | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Method of producing amorphous paroxetine hydrochloride |
| HU221921B1 (hu) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására |
| EP0994872B9 (en) * | 1997-06-10 | 2001-12-05 | Synthon B.V. | 4-phenylpiperidine compounds |
| JP2002505254A (ja) * | 1998-02-06 | 2002-02-19 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | パロキセチン塩 |
-
1998
- 1998-07-02 GB GBGB9814316.7A patent/GB9814316D0/en not_active Ceased
-
1999
- 1999-04-23 ZA ZA9902899A patent/ZA992899B/xx unknown
- 1999-06-30 JP JP2000558095A patent/JP2002519421A/ja active Pending
- 1999-06-30 EA EA200100098A patent/EA200100098A1/ru unknown
- 1999-06-30 TR TR2001/00055T patent/TR200100055T2/xx unknown
- 1999-06-30 SK SK2024-2000A patent/SK20242000A3/sk unknown
- 1999-06-30 AU AU49039/99A patent/AU4903999A/en not_active Abandoned
- 1999-06-30 KR KR1020007015100A patent/KR20010053337A/ko not_active Application Discontinuation
- 1999-06-30 IL IL14038599A patent/IL140385A0/xx unknown
- 1999-06-30 PL PL99345365A patent/PL345365A1/xx not_active Application Discontinuation
- 1999-06-30 CN CN99810197A patent/CN1314906A/zh active Pending
- 1999-06-30 AP APAP/P/2000/002017A patent/AP2000002017A0/en unknown
- 1999-06-30 WO PCT/EP1999/004543 patent/WO2000001692A1/en not_active Application Discontinuation
- 1999-06-30 ID IDW20010252A patent/ID27766A/id unknown
- 1999-06-30 EP EP99932772A patent/EP1091958A1/en not_active Withdrawn
- 1999-06-30 CZ CZ20004923A patent/CZ20004923A3/cs unknown
- 1999-06-30 BR BR9911679-0A patent/BR9911679A/pt not_active Application Discontinuation
- 1999-06-30 HU HU0103712A patent/HUP0103712A3/hu unknown
- 1999-06-30 CA CA002336470A patent/CA2336470A1/en not_active Abandoned
-
2000
- 2000-12-21 NO NO20006547A patent/NO20006547L/no not_active Application Discontinuation
-
2001
- 2001-01-02 ZA ZA200100020A patent/ZA200100020B/en unknown
- 2001-01-31 BG BG105204A patent/BG105204A/xx unknown
- 2001-07-11 AU AU2002100370A patent/AU2002100370A4/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010053337A (ko) | 2001-06-25 |
| WO2000001692A1 (en) | 2000-01-13 |
| SK20242000A3 (sk) | 2001-07-10 |
| NO20006547D0 (no) | 2000-12-21 |
| CZ20004923A3 (cs) | 2001-08-15 |
| NO20006547L (no) | 2001-02-12 |
| ZA992899B (en) | 2000-03-29 |
| AP2000002017A0 (en) | 2000-12-31 |
| ZA200100020B (en) | 2002-03-25 |
| AU2002100370A4 (en) | 2002-06-06 |
| HUP0103712A2 (hu) | 2002-05-29 |
| EA200100098A1 (ru) | 2001-08-27 |
| PL345365A1 (en) | 2001-12-17 |
| IL140385A0 (en) | 2002-02-10 |
| GB9814316D0 (en) | 1998-09-02 |
| HUP0103712A3 (en) | 2002-09-30 |
| CA2336470A1 (en) | 2000-01-13 |
| BG105204A (en) | 2001-11-30 |
| JP2002519421A (ja) | 2002-07-02 |
| BR9911679A (pt) | 2002-01-29 |
| ID27766A (id) | 2001-04-26 |
| EP1091958A1 (en) | 2001-04-18 |
| TR200100055T2 (tr) | 2001-07-23 |
| CN1314906A (zh) | 2001-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4903999A (en) | Salts of paroxetine | |
| US4499299A (en) | Pharmaceutically active phenylcarboxylic acid derivatives | |
| TW199152B (no) | ||
| ES2438240T3 (es) | Nuevos derivados de biaril benzoimidazol y composición farmacéutica que los comprenden | |
| KR100938950B1 (ko) | 치환 페닐 알칸산 유도체 및 그 용도 | |
| AU2002350315B2 (en) | Quinolinones as prostaglandin receptor ligands | |
| CZ147797A3 (cs) | Substituované 4-biarylmáselné nebo 5-biarylpentanové kyseliny a deriváty jako inhibitory matricové metalloproteasy | |
| AU2001254555A1 (en) | Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore | |
| HU183085B (en) | Process for preparing new phenoxy-alkyl-carboxylic acid derivatives and pharmaceutical compositions containing thereof | |
| JP4846978B2 (ja) | タンパク質チロシンホスファターゼのオキシンドールヒドラジンモジュレータ | |
| JP2001055367A (ja) | ヒトペルオキシゾーム増殖薬活性化受容体（ＰＰＡＲ）αアゴニストとしての置換フェニルプロピオン酸誘導体 | |
| SU1443800A3 (ru) | Способ получени производных тиазолидин-4(S)-карбоновой кислоты или ее солей с щелочными или щелочноземельными металлами,или ее сложных эфиров | |
| JP2010143937A (ja) | 抗凝血薬として用いるクマリン誘導体 | |
| AU776831B2 (en) | Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment | |
| JP6310931B2 (ja) | Ｇｐｒ１２０アゴニストとしてのチオアリール誘導体 | |
| TWI415833B (zh) | 脂氧素（ｌｉｐｏｘｉｎ）ａ4類似物之結晶鉀鹽 | |
| JPH04270261A (ja) | イソプレノイドホスホリパーゼ▲ａ２▼阻害剤およびそれを包含する製剤 | |
| EP1654247A1 (en) | Alkynyl aryl carboxamides | |
| KR20080015788A (ko) | ＧｌｙＲ의 조정제 또는 아고니스트인 벤조산 유도체 | |
| MXPA01000133A (en) | Salts of paroxetine | |
| EP1165491B1 (fr) | Inhibiteurs de lta4 hydrolase | |
| JPWO2020092823A5 (no) | ||
| US20040186081A1 (en) | Naaladase inhibitors for treating opioid tolerance | |
| HRP950558A2 (en) | Substituted 4-biarylbutric or biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors | |
| JP2002506851A (ja) | カルボン酸類およびアシルスルホンアミド類、そのような化合物を含む組成物ならびに治療方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |